Clinical Trial Update: PNEUMOSTEM for the Prevention and Treatment of Severe BPD in Premature Infants [Phase 2]

View source ↗

Summary

Phase 2 trial of PNEUMOSTEM for prevention and treatment of severe bronchopulmonary dysplasia in premature infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• PNEUMOSTEM

Snippet

Sponsor: Medipost Co Ltd. | Conditions: Severe Bronchopulmonary Dysplasia | Phase 2 | Status: COMPLETED